In this article, the authors review the types of molecular alterations present in cancer and molecular methods used commonly in clinical diagnostic laboratories, including technologies such as next-generation sequencing and digital polymerase chain reaction. Additionally, the authors discuss considerations for test design, incorporating factors such as specimen type and biomarker type, to design a molecular test menu that delivers accurate and timely results in an efficient and cost-effective manner.